Please refer to the outcome of the Board meeting held on 07.08.2026

GB GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE &FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TEL: 0260-2430027 / 2400639 E-mail:hrm@gtbl.in.net GTBL/BSE/NSE/2026-27/45 7th August, 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Scrip Code – 506879 Bandra (East), Mumbai- 400051 Symbol: GUJTHEM Dear Sir / Madam, Sub: Outcome of Board Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) The Board of Directors at its meeting held today, have approved the Un-Audited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2026. A copy of Un-Audited Standalone & Consolidated Financial Results for the quarter ended 30th June, 2026 together with the limited review reports of the Statutory Auditor is attached herewith. The Board meeting commenced at 10.30 A.M (IST) and concluded at 12.55 P.M (IST). The above is for your information and dissemination. Thanking you, Yours faithfully, For GUJARAT THEMIS BIOSYN LIMITED Vineet Gawankar Company Secretary & Compliance Officer Encl.: a/a. MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104 Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019; E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in GUJARATTHEMIS BIOSYN LIMITED CIN:L24230GJ1981PLC004878 69/C, GIDC Industrial Estate, Vapi -396 19S, Dist. Valsad, Gujarat Tel: +91 260 2430027 Fax: +91 260 2400639 E-mail: admln@gtbl.ln.net Website: www.gtbl.ln Statement of Unaudited Standalone Financial Results for the Quarter ended June 30, 2026 /Amount in INR lakhs) Sr. Quarter Ended Year Ended PARTICl)LARS 30.06.2026 31.03.2026 30.06.2025 31.03.2026 (Unaudlted) (Audited) (Unaudited) (Audited) I Income from operat;ons 4.379.00 4,423.30 3,587.28 16.582.28 II Other lntome 13.i7 92.11 27.44 242.81 Iii Totai Income (1+111 4,392:16 4,515.41 3,614.72 16,825.09 IV Evpendltu,e a) Cost of raw material consumed 772.91 1,005.48 682.59 3 042.86 /bl Purcha<es of stock-in-trade (c) Changes in inventories of Finished Goods. Work-in-Progress (391.10) (649.95) (19 ·sai (902.75) and Stock in Trade d) Employee bendits expense 472.13 379.40 311.19 1,651.06 lie) Finance Cost 178.70 190 60 4.21 294 89 'fl Oepr-,cioiion and Amortisation e,penses 397.29 403.84 203 38 1,291.93 (g) Other E•penses il Stores and soares 156 62 134.54 13698 617.79 ii) Power 672.20 792.37 517.66 2,458 86 iii) Fuel 169 82 197.25 14667 611.20 Iv) Water 26.49 34.65 2860 118 81 v) Other e,penditure 420.58 593.58 391.36 1,431.44 Total Expenses 2,875.63 3,081.76 2,402.76 10,616.08 V Profit/Closs) before Exceotional Items and Tax ·1111-IVI 1,516.53 1,433.65 1,211.96 6,209.00 VI f•tepUonal items VII Profit/Closs) before Tax IV-Vil 1,516.53 1,433.65 1,211.96 6,209.00 VIII Tax expenses (a) Current Tax 27166 237.55 246 64 1.078.63 (b) Def,m.,d Tax 138 20 10698 59.16 462.23 (c) Income Tax of earlier years IX Net Prorit/(loss) after tax {VII-VIII) 1,106.67 1,089.12 906.16 4,668.15 X Other Comprehensive Income (A) Items that will not be reclassified to Profit or Loss (i) remeasurement of defined benefit plans; 0.17 0.56 1.70 0.67 (ii) lncume Tax relating to items that will not be (0.04) (0.14) (0.43) (017) recl a<s;foed to Profit or Loss Bl Items that will be reclassified to Profit or Loss . . Total Other Comprehensive lncome/(lossl 0.13 0.42 1.27 0 50 XI Total Comprehensive Income for the period (IX+X) 1,106.80 1,089.54 907.44 4,668.65 XII Paid-up equity share cap;tal 1.089 65 1,089 65 1.089 65 1,089.65 )(111 Other Equity 27,687.13 XIV Earnings Per Share (Basic and Diluted) 1.02 1.00 0.83 4.28 Notes: 1 The above quarter ended June, 2026 unaudited standalone financial results have been reviewed by the Audit committee on 7th August, 2026 and approved by the Bodrd of Dir.,ctors. The Statutory Auditors have carried out an limited review of th..se financial results and giv,;n unmodified conclusion on the same. 2 The Company operat@s only in one Business Segment i.e. manufacturing of fermentaUon-based pharmaleutical Intermediates and APls, hente does not have any reportable segments as per Indian Accounting Standard (Ind AS)-108 "Op.,rdting Se5ments". 3 The above findnical results have been prepared in accordance with Indian Accounting Standards (Ind AS) as pr,;scribed under section 133 of the Compani~s Act, 2013 ,.,ad with Rule 3 of the Companies (Indian Accounting Standards) Rules, 2015 and relevdnt amendments thereafter. 4 The figures of the previous quarter ended March 31, 2C16 are the balancir,g figures between audited figures of the full financial year and the published y,;ar-to• date fieures for the nine months ended. 5 Figures of pr.,viuus p,;riods/years' have been regrouped/ redrraneed, wherev"r considered necessary. Place: Mumbai Date : August 7, 2026 ---- C - -- ~-- --- -~-- ---- ~- --- Chartered Accountants 3rd & 4th Floor, Vaastu Darshan 'B'wing, Above Central Bank of l~dia Azad Road, Andheri (East), ' Mumbai -400 069. Tel. : 022-6191 9293 / 222 /200 Fax : 022-2684 2221 / 6191 9256 E-mail : admin@gmj.co.in info@gmj.co in Independent Auditor's Review Report on Quarterly Unaudited Standalone Financial Results and Year to Date Results Of Gujarat Themis Biosyn Limited pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Review report to The Board of Directors GUJARAT THEM IS BIOSYN LIMITED We have reviewed the accompanying statement of Unaudited Standalone financial results of Gujarat Themis Biosyn Limited ('the Company'} for the quarter ended June 30, 2026 ("the Statement"} attached herewith, being submitted by the Company pursuant to the requirement of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements} Regulations, 2015, as amended ("Listing Regulation") read with circular (Circular No. CIR/CFD/CMDl/80/2019 dated July 19, 2019) issued by the SEBI under Regulation 33 (8} of the SEBI (Listing Obligations and Disclosure Requirements} Regulation, 2015, as amended, to the extent applicable. This statement is the responsibility of the Company's Management and has been approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" (Ind AS 34), prescribed under Section 133 of Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to issue a report on these financial statements based on our review. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE} 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the statement is free of material misstatement. A review is limited primarily to GTBL/IARR-5/F.Y. 2026-27/ Ql Page lof 2 Chartered Accountants inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review, conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement, prepared in accordance with applicable Indian Accounting Standards prescribed under section 133 of Companies Act 2013 read with rules issued thereunder and other recognized accounting practices and policies generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the S [Showing first 8,000 characters — download PDF for full document]